SWOT Analysis for Sutro Biopharma Inc

Stocks whose current price is 20% higher than week low, and more than previous close
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Top Gainers

Promoter decreasing their shareholding
Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)
Negative profit growth, promoters decreasing shareholding QoQ
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Low DVM Stocks - Stocks to Exercise Caution On
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Highest fall from 52 Week High
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Low Piotroski Score : Companies with weak financials
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
Declining profits every quarter for the past 2 quarters
RSI indicating price weakness
Stocks Underperforming their Industry Price Change in the Quarter